Current Issue
Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3
Robert Dream, Managing Director, HDR Company LLC
Advances and Challenges in Vaccine Development and Manufacture
Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...
Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...
Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...
Lifetime Study for JSR Amsphere A3 – Protein A Resin
JSR Life Sciences
Featured Articles
Overcoming Obstacles in AAV Viral Vector Manufacturing
Continuous processing optimization with smarter tools
Barbara Paldus, Ph.D.
Vice President & General Manager Finesse, part of Thermo Fisher Scientific
Current Status of Analytical Techniques for Characterization of Protein Stability
Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning
Navigating Technology Transfer
View All Featured ArticlesHeadline News
BeOne Medicines, BeOne Care Foundation, and The Max Foundation extend collaboration to broaden access to BRUKINSA for chronic lymphocytic leukemia patients in low- and middle-income countries
Hibsago receives approval in Japan as the first and only functional cure for chronic hepatitis B
FDA approves Regeneron’s Pasatru the first treatment shown to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in a placebo-controlled trial for adults with fibrodysplasia ossificans progressiva
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Rapid Microbiology Applications in the COVID-19 Era
Presented by Presented by Dr. Michael J. Miller, President of Microbiology Consultants, LLC, Ulrich Herber Director of Technology and Market Development Charles River and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
04th August 2020
Establishing Early Development Strategies For Therapeutics Proteins
Presented by Sorina Morar-Mitrica, Principal Fellow Sr Drug Product Lead Early Phase Biologics at Novartis and Bernardo Cordovez, PhD, Chief Science Officer & Founder, Halo Labs
21st October 2020
Risk Assessment of Extractables and Leachables in Different Phases of Development.
Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals and Ward d’Autry, Study Director E/L & Structural Elucidation, Nelson Labs Europe
22nd April 2021
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere TM A3
Strategy Emerging Markets for Risk Mitigation
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
